Enhance your patent search with AI. Try the FREE AI-powered tool

Drug patent listing and exclusivity clarified in new US bill

drug tablets

The Orange Book Transparency Act of 2020 (H.R. 1503) was signed into law last January 5, 2021. The Act updates regulations of the US Food and Drug Administration concerning the Approved Drug Products with Therapeutic Equivalence Evaluations (more commonly known as the Orange Book) which contains publicly available patent and exclusivity information, particularly on approved and available generic drugs.

US denied dismissal of contract breach claims in Gilead patent dispute

Truvada tablets that are color blue

An interesting corner of the growing world of AI is its adoption in the automotive industry. As automakers are racing to develop driverless vehicles for widespread adoption, they recognize that leveraging AI-powered solutions and features will be the key differentiators for their brand.

Subscribe to our newsletter

  • Questions? Check our privacy policy.
  • This field is for validation purposes and should be left unchanged.

Patent and IP updates straight to your inbox

Sign up now to receive monthly patent news, analysis and free insight reports.

We don’t spam, we promise.


1. Parola Analytics and Avontis are distinct entities and operate independently. Any references to Avontis or its services do not constitute a legal partnership. 

2. Parola Analytics does not provide legal services. Our services are limited to research and technical analysis. Any information provided by Parola Analytics should not be construed as legal advice.